Orthopedic Surgery, Sports Medicine · New Iberia, LA
NPI
1629175633
Since 2006
Specialty
Orthopedic Surgery, Sports Medicine
Code 207XX0005X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1307 Old Jeanerette Rd, Suite 100
New Iberia, LA, 70563
Phone (337) 364-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
8,527 services
Medicare patients, 2024
327
Average age 73
Drug cost, 2024
$231K
4,639 prescriptions
Company payments, 2025
$269
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William A Cenac was code J1010 (injection, methylprednisolone acetate, 1 mg), 5,398 times for 128 patients. In total William A Cenac billed 8,527 services in 88 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,398 | 128 | $0.10 | $542 |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 1,225 | 19 | $13.64 | $17K |
| 99213 Office E&M - Established | Office | 574 | 255 | $54.00 | $31K |
| 20610 Joint Injection | Office | 305 | 142 | $45.28 | $14K |
| 99212 Office E&M - Established | Office | 198 | 135 | $32.88 | $6,509 |
| 73562 X-ray - Lower Extremity | Office | 135 | 87 | $24.48 | $3,304 |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 89 | 21 | $56.51 | $5,029 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 73 | 51 | $4.21 | $307 |
| 99203 Office E&M - New | Office | 65 | 65 | $60.86 | $3,956 |
| 73501 X-ray - Lower Extremity | Office | 48 | 37 | $20.05 | $962 |
| 73030 X-ray - Upper Extremity | Office | 47 | 41 | $20.60 | $968 |
| 72110 X-ray - Spine and Pelvis | Office | 30 | 27 | $26.69 | $801 |
| 73630 X-ray - Lower Extremity | Office | 27 | 19 | $19.88 | $537 |
| 73610 X-ray - Lower Extremity | Office | 21 | 14 | $22.38 | $470 |
| 20605 Joint Injection | Office | 20 | 14 | $31.73 | $635 |
By year: 2022 $195K for 9,241 services; 2023 $163K for 5,939 services; 2024 $128K for 8,527 services.
Medicare prescription drug claims, 2024
In 2024, the drug William A Cenac prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,810 prescriptions and refills. In total William A Cenac wrote 4,639 Medicare prescriptions that cost $231K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,810 | 1,810 | 273 | $32K |
| Meloxicam Generic | 834 | 916 | 194 | $2,045 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 444 | 444 | 88 | $12K |
| Tizanidine Hcl Generic | 429 | 470 | 100 | $2,345 |
| Tramadol Hcl Generic | 183 | 183 | 45 | $1,645 |
| Gabapentin Generic | 147 | 161 | 24 | $1,415 |
| Celecoxib Generic | 143 | 173 | 34 | $1,953 |
| Cyclobenzaprine Hcl Generic | 94 | 105 | 17 | $821 |
| Tolmetin Sodium Generic | 51 | 51 | 20 | $124K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 43 | 43 | 29 | $227 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 40 | 40 | Under 11 | $1,168 |
| Orphenadrine-Aspirin-Caffeine Orphenadrine/Aspirin/Caffeine | 39 | 39 | Under 11 | $30K |
| Pregabalin Generic | 33 | 48 | Under 11 | $717 |
| Methylprednisolone Generic | 28 | 28 | 24 | $191 |
| Prednisone Generic | 27 | 27 | 18 | $56.43 |
Brand drugs: 31 claims; generic drugs: 4,608 claims; opioid claims: 2,491.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William A Cenac $269 ($269 in general payments such as food, travel and fees) from 4 companies. The largest payer was Stryker Corporation with $174.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.